申请人:Phone-Poulenc Sante
公开号:US04576954A1
公开(公告)日:1986-03-18
New derivatives of the general formula (I) in which: R=H or Cl and either R.sub.1 and R.sub.2 form a tetrahydroquinoxaline, tetrahydroquinoline, tetrahydroisoquinoline, dihydrobenzoxazine, tetrahydro-1H-benzazepine or isoindoline ring, it being possible for all these rings to be substituted by one or more halogen, carboxyl, alkoxycarbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, trifluoromethyl, cyano, nitro, alkoxy, alkylthio or alkyl, substituted by carboxyl, alkoxycarbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, hydroxyl, amino, alkylamino or dialkylamino, or R.sub.1 =alkyl and R.sub.2 =alkyl substituted by phenyl which is itself unsubstituted or substituted by one or more halogen, alkyl, alkoxy, alkylthio, hydroxy, amino, alkylamino, dialkylamino, carboxy, alkoxycarbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, trifluoromethyl, cyano or nitro, all the alkyls having 1 to 4 C in a straight or branched chain. These new products are used as antirheumatics. ##STR1##
通式(I)的新衍生物,其中:R = H或Cl,且R.sub.1和R.sub.2形成四氢喹喔啉,四氢喹啉,四氢异喹啉,二氢苯并噁嗪,四氢-1H-苯并氮杂环或异吲哚烷环,所有这些环都可以被一个或多个卤素,羧基,烷氧羰基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,三氟甲基,氰基,硝基,烷氧基,烷基硫基或烷基取代,被羧基,烷氧羰基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,羟基,氨基,烷基氨基或二烷基氨基取代,或R.sub.1 = 烷基且R.sub.2 = 烷基被苯基取代,该苯基本身未被取代或被一个或多个卤素,烷基,烷氧基,烷基硫基,羟基,氨基,烷基氨基,二烷基氨基,羧基,烷氧羰基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,三氟甲基,氰基或硝基取代,所有烷基都是直链或支链,碳数为1到4。这些新产品用作抗风湿药物。 ## STR1 ##